InsiderSignal.AI

InsiderSignal.ai

BVS - Bioventus Inc.

Insider Sale by McMurry-Heath Michelle (Dir)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

4 days ago, McMurry-Heath Michelle, serving as Dir at Bioventus Inc. (BVS), sold 12,000 shares at $8.79 per share, for a total transaction value of $105,439.00. Following this transaction, McMurry-Heath Michelle now holds 44,997 shares of BVS.

This sale represents a 21.00% decrease in McMurry-Heath Michelle's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, March 11, 2026 and publicly disclosed via SEC Form 4 filing on Friday, March 13, 2026, 2 days after the trade was made.

Bioventus Inc. operates in the HEALTHCARE sector, specifically within the MEDICAL DEVICES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

McMurry-Heath Michelle

Dir

Michelle McMurry-Heath, MD, PhD (age 55) is an independent Director at Revvity, Inc. (RVTY) since July 2022, serving on the Compensation & Benefits Committee.[[1]](https://fintool.com/app/research/companies/RVTY/people/michelle-mcmurry-heath)[[2]](https://www.revvity.com/company/leadership)[[4]](https://news.revvity.com/press-announcements/press-releases/press-release-details/2022/PerkinElmer-Elects-Dr.-Michelle-McMurry-Heath-to-its-Board-of-Directors/default.aspx) A physician and molecular immunologist, she earned a BA in biochemistry from Harvard University and an MD/PhD from Duke’s Medical Scientist Training Program, becoming the first African American graduate, followed by 12 years of bench research.[[1]](https://fintool.com/app/research/companies/RVTY/people/michelle-mcmurry-heath)[[2]](https://www.revvity.com/company/leadership)[[4]](https://news.revvity.com/press-announcements/press-releases/press-release-details/2022/PerkinElmer-Elects-Dr.-Michelle-McMurry-Heath-to-its-Board-of-Directors/default.aspx) Her career highlights include leadership as President and CEO of the Biotechnology Innovation Organization (BIO) (2020–2022), where she advocated for biotech innovation and equitable access to scientific progress; senior roles at Johnson & Johnson (2014–2020) as Global Head of Evidence Generation for Medical Devices, VP of Global External Innovation, and Global Leader for Regulatory Sciences; and government positions such as Associate Science Director at the U.S. FDA’s Center for Devices and Radiological Health (CDRH).[[1]](https://fintool.com/app/research/companies/RVTY/people/michelle-mcmurry-heath)[[2]](https://www.revvity.com/company/leadership)[[4]](https://news.revvity.com/press-announcements/press-releases/press-release-details/2022/PerkinElmer-Elects-Dr.-Michelle-McMurry-Heath-to-its-Board-of-Directors/default.aspx)[[5]](https://www.nti.org/about/people/michelle-mcmurry-heath/) Currently, she is Founder and CEO of BioTechquity Clinical (since 2024), a CRO focused on diverse clinical trial enrollment, and serves as a Director at Bioventus Inc..[[1]](https://fintool.com/app/research/companies/RVTY/people/michelle-mcmurry-heath)[[2]](https://www.revvity.com/company/leadership) On February 23, 2026, she sold 600 shares of RVTY at $97.26 per share.[[3]](https://www.gurufocus.com/news/8653101/insider-sell-michelle-mcmurryheath-sells-shares-of-revvity-inc-rvty)[[7]](https://www.stocktitan.net/sec-filings/RVTY/form-4-revvity-inc-insider-trading-activity-ef8df23cd9ca.html)

View full insider profile →

Trade Price

$8.79

Quantity

12,000

Total Value

$105,439.00

Shares Owned

44,997

Trade Date

Wednesday, March 11, 2026

4 days ago

SEC Filing Date

Friday, March 13, 2026

Filed 2 days after trade

HEALTHCAREMEDICAL DEVICES

About Bioventus Inc.

Company Overview

No company information available
View news mentioning BVS

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/4753858

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime